AKT1 and ovarian carcinoma: TCP1 encodes a molecular chaperone protein that modulates the PI3K/AKT/mTOR signaling pathway, thereby promoting ovarian cancer cell proliferation (Weng et al. 2021) and enhancing drug resistance in acute myeloid leukemia (Chen et al. 2021).